Mandibulofacial Acrofacial dysostosis

Gene: SHROOM3

Amber List (moderate evidence)

SHROOM3 (shroom family member 3)
EnsemblGeneIds (GRCh38): ENSG00000138771
EnsemblGeneIds (GRCh37): ENSG00000138771
OMIM: 604570, Gene2Phenotype
SHROOM3 is in 4 panels

1 review

Chirag Patel (Genetic Health Queensland)

I don't know

SHROOM3 has been implicated in facial development via GWAS, with association between SHROOM3 and HFM, cleft lip/palate, orofacial clefts, and neural tube defects. Human embryo expression data shows that SHROOM3 is mainly expressed in craniofacial mesoderm, neural progenitor cells, and somites in the head and trunk regions. Mouse Genome Informatics data shows that Shroom3 is expressed in various tissues during different stages of embryonic development, including the head mesenchyme, ear, eye, face, and nose.

Li et al. (2025) performed SHROOM3 gene sequencing in 320 sporadic hemifacial microsomia patients. They identified 7 individuals with 7 deleterious missense variants (MAF <0.005, CADD >20, predicted deleterious with >3 silico tools). No in vitro/in vivo functional studies to assess the consequences of the variants and their role in HFM.
Sources: Literature
Created: 6 Feb 2025, 4:21 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Craniofacial microsomia MONDO:0015397

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Amber
  • Literature
Phenotypes
  • Craniofacial microsomia MONDO:0015397
OMIM
604570
Clinvar variants
Variants in SHROOM3
Penetrance
None
Publications
Panels with this gene

History Filter Activity

7 Feb 2025, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: shroom3 has been classified as Amber List (Moderate Evidence).

6 Feb 2025, Gel status: 2

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: shroom3 has been classified as Amber List (Moderate Evidence).

6 Feb 2025, Gel status: 2

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: shroom3 has been classified as Amber List (Moderate Evidence).

6 Feb 2025, Gel status: 2

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: shroom3 has been classified as Amber List (Moderate Evidence).

6 Feb 2025, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Chirag Patel (Genetic Health Queensland)

gene: SHROOM3 was added gene: SHROOM3 was added to Mandibulofacial Acrofacial dysostosis. Sources: Literature Mode of inheritance for gene: SHROOM3 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: SHROOM3 were set to PMID: 39875538 Phenotypes for gene: SHROOM3 were set to Craniofacial microsomia MONDO:0015397 Review for gene: SHROOM3 was set to AMBER